Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity-Reference-Cited by-同舟云学术

Glucagon-Like Peptide 1 Protects against Hyperglycemic-Induced Endothelial-to-Mesenchymal Transition and Improves Myocardial Dysfunction by Suppressing Poly(ADP-Ribose) Polymerase 1 Activity

Published:2015-01 Issue:1 Volume:21 Page:15-25
ISSN:1076-1551
Container-title:Molecular Medicine
language:en
Short-container-title:Mol Med

Author:

Yan Fei,Zhang Guang-hao,Feng Min,Zhang Wei,Zhang Jia-ning,Dong Wen-qian,Zhang Cheng,Zhang Yun,Chen Li,Zhang Ming-Xiang

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.2119/molmed.2014.00259.pdf

Reference39 articles.

1. Rosenbloom J, Castro SV, Jimenez SA. (2010) Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies. Ann. Intern. Med. 152:159–66.

2. Wei J, Bhattacharyya S, Tourtellotte WG, Varga J. (2011) Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy. Autoimmunity Reviews. 10:267–75.

3. Wynn TA. (2008) Cellular and molecular mechanisms of fibrosis. J. Pathol. 214:199–210.

4. Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R. (2007) Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 67:10123–8.

5. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R. (2008) Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J. Am. Soc. Nephrol. 19:2282–7.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ADP-ribosylation, a multifaceted modification: Functions and mechanisms in aging and aging-related diseases;Ageing Research Reviews;2024-07

2. Interplay Between TGF-β Signaling and MicroRNA in Diabetic Cardiomyopathy;Cardiovascular Drugs and Therapy;2023-12-20

3. miR-132-3p and KLF7 as novel regulators of aortic stiffening-associated EndMT in type 2 diabetes mellitus;Diabetology & Metabolic Syndrome;2023-01-25

4. The role of endothelial-mesenchymal transition in vascular restenosis after endovascular treatment in patients with peripheral arterial disease of the lower extremities;Kardiologiya i serdechno-sosudistaya khirurgiya;2023

5. The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications;Oxidative Medicine and Cellular Longevity;2022-09-06